Welcome to our dedicated page for NOVA LTD. SEC filings (Ticker: NVMI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Nova Ltd. filings document its foreign private issuer reporting for a semiconductor metrology and process control company. Form 6-K current reports incorporate press releases on financial results, scheduled earnings releases, investor conference participation, product adoption for Nova Metrion®, and other operating updates. The Form 20-F annual report includes audited consolidated financial statements and establishes the company's reporting framework under Form 20-F rather than Form 40-F.
The filing record also identifies Nova's Nasdaq ticker NVMI and TASE trading status. Current reports preserve formal notices for annual-report availability, scheduled conference calls and public communications made under Exchange Act Rule 13a-16 or 15d-16.
NOVA Ltd. (NVMI) has filed a Form 144 indicating a planned sale of insider shares. The filing covers 1,390 ordinary shares to be sold through Oppenheimer & Co. on or after 30 June 2025. At the stated aggregate market value of $372,019.60, the implied per-share price is approximately $267. The company reports 29.28 million shares outstanding, so the proposed sale represents roughly 0.005 % of total shares—an immaterial fraction in ownership terms.
The seller—identified in the past-three-month sales table as Simon Zehava—has already sold 855 shares over the previous week (24 & 26 June 2025) for combined gross proceeds of $221,040. The shares being sold were originally acquired on 25 June 2020 as Restricted Stock Units issued by NOVA. No cash consideration or 10b5-1 plan details are disclosed in the filing.
Because Form 144 is a notice rather than a completed transaction, the sale may or may not be executed depending on market conditions. Given the very small size relative to the float and the absence of material adverse information in the filing, the event is unlikely to have a meaningful impact on NOVA’s share price or fundamentals.
Nova Ltd Director Simon Zehava has filed Form 144 indicating a proposed sale of 720 ordinary shares with an aggregate market value of $183,852. The sale is planned to execute on June 26, 2025 through Oppenheimer & Co. Inc. on the Nasdaq exchange.
The shares were originally acquired on June 17, 2019, as Restricted Stock Units from the issuer. The filing reveals this sale is being conducted under a 10b5-1 trading plan adopted on December 2, 2024.
Recent trading activity shows Zehava previously sold 135 ordinary shares on June 24, 2025, for gross proceeds of $32,400. The company currently has 29,278,401 shares outstanding.
This planned transaction represents a relatively small portion of Nova's total outstanding shares and is being executed through a pre-planned trading arrangement, suggesting a routine insider sale rather than a significant strategic divestment.
Nova Ltd. (ticker NVMI) has filed a Form 144 with the U.S. Securities and Exchange Commission disclosing a planned sale of 2,051 ordinary shares. The shares will be sold through Oppenheimer & Co. Inc. on or about 25 June 2025 on the Nasdaq exchange. The filing assigns an aggregate market value of approximately US$509,714 to the proposed transaction, implying a reference price of roughly $248/share. Nova reports a total of 29,278,401 shares outstanding, so the planned sale represents only about 0.007 % of the float.
The seller previously disposed of 1,000 ordinary shares on 11 June 2025 for gross proceeds of US$235,000, indicating recent activity under Rule 144. Acquisition data show the shares originated from restricted stock unit (RSU) grants dated 31 Oct 2018 (730 sh), 6 Nov 2019 (664 sh) and 11 Nov 2020 (867 sh). No cash consideration or gifting was involved in the original awards.
The notice includes the standard representation that the seller is not in possession of undisclosed material adverse information. No Rule 10b5-1 plan date is provided, and no remarks were added by the filer.
For investors, the filing signals a modest insider monetisation event but, given its de-minimis size relative to the total share count, it is unlikely to have a material impact on Nova’s share-price dynamics.